Wellferon

Wellferon®

Lymphoblastoid IFN alfa-n1 Immunology A drug used for KS, hairy cell leukemia, HCV in Pts w/o active liver disease. See Interferon.

Wellferon

A brand name for INTERFERON ALFA.
Mentioned in ?
References in periodicals archive ?
Because the criteria for ascertaining anti-SARS-CoV activity in this screen were set at 100% inhibition of CPE, and as high doses of interferons may result in severe clinical side effects, we chose to conduct further evaluations only in the interferons that showed complete inhibition from initial screen, namely, Wellferon, Multileron, Betaleron, and Alferon.
Betaferon, Alferon, Multiferon, Wellferon, and ribavirin inhibited CPE in SARS-CoV-infected Vero E6 cells, in decreasing order of potency.
Of our other patented prescription products, WELLFERON (interferon alfa-nl (lns)), continues to perform particularly well with sales of $28m, an underlying growth of 54 percent.
For example, a major three drug therapy trial, evaluating RETROVIR, ddc and WELLFERON is being conducted by us in the USA.
Wellferon is marketed as a treatment for hairy cell leukemia and chronic active hepatitis B in a number of countries.